# Vik Vaz

> Vik Vaz is a physician-turned-executive who became CEO and President of San Diego multi-omics biotech Pleno Inc. in December 2024, arriving the same day the company closed a $25M Series B. Trained as a surgeon and interventional oncologist, he later ran strategy and companion diagnostics at Illumina and was a partner at both McKinsey and Boston Consulting Group. At Pleno he is commercializing the RAPTOR platform, which uses proprietary Hypercoding technology to detect DNA, RNA and protein targets in a single sample at high speed and low cost.

- **Role:** Chief Executive Officer & President at Pleno Inc.
- **Organizations:** Pleno Inc., Illumina, Boston Consulting Group, McKinsey & Company, Beth Israel Deaconess Medical Center, University of Miami
- **Nationality:** American
- **Education:** Undergraduate (alumnus), Harvard College, Education completed, University of Texas, Surgical training and clinical instructor, Harvard Medical School / Beth Israel Deaconess Medical Center, Radiology and interventional oncology training, University of Miami
- **Known for:** Appointed CEO & President of Pleno Inc. concurrent with a $25M Series B financing (December 2024), Led companion diagnostics business and enterprise strategy at Illumina, Made partner at both McKinsey & Company and Boston Consulting Group

## Career timeline

- **—** — Trained as a surgeon and clinical instructor at Harvard Medical School's Beth Israel Deaconess Medical Center
- **—** — Trained in radiology and interventional oncology at the University of Miami
- **—** — Partner at McKinsey & Company advising pharma, med-tech and life sciences leaders
- **—** — Partner at Boston Consulting Group driving growth and strategic transformations
- **—** — Head of Strategy & Market Intelligence and leader of the Companion Diagnostics business at Illumina
- **2024** — Appointed CEO & President of Pleno Inc. and joined its Board of Directors, December 2024, coinciding with a $25M Series B close

## Achievements

- Appointed CEO & President of Pleno Inc. concurrent with a $25M Series B financing (December 2024)
- Led companion diagnostics business and enterprise strategy at Illumina
- Made partner at both McKinsey & Company and Boston Consulting Group
- Remains an actively licensed physician trained as a surgeon and interventional oncologist
- Oversaw Pleno's commercial launch of the RAPTOR multi-omics platform, including an agreement with Slopes Bio

## Latest updates

- **2024-12** — Named CEO & President of Pleno and joined the board as the company closed a $25M Series B led by investors including Deerfield Management, Foresite Capital and Medical Excellence Capital.
- **2025** — Pleno moved toward commercialization of the RAPTOR multi-omics platform, including a commercial agreement with Utah-based Slopes Bio, Inc.

## Links

- Website: https://plenoinc.com
- LinkedIn: https://www.linkedin.com/in/vik-vaz/
- Twitter/X: https://twitter.com/vaz_vik

---

Profile page: https://yespress.io/vik-vaz
Published by YesPress — https://yespress.io
Last updated: 2026-06-04